Motion · S5M-16986 · 18 Apr 2019
FDA and Mesh
The motion
That the Parliament notes that the US Federal Drugs Administration (FDA) has asked Boston Scientific and Coloplast, which it understands are the two largest manufacturers of mesh currently used in pelvic organ prolapse in women, to remove it from the US market; believes that this comes after the companies failed to satisfy the FDA of the safety and efficacy of their products; considers that this move stands in contrast to the NICE guidelines in England, published only two weeks earlier, which placed a much lower threshold for the safety of women in the UK and recommended its use, and calls for this guideline not to be implemented in Scotland.
Supporters (9)
- Mark Griffin Scottish Labour 18 Apr 2019
- James Kelly 18 Apr 2019
- Monica Lennon Scottish Labour 18 Apr 2019
- Alex Neil 18 Apr 2019
- Tavish Scott 18 Apr 2019
- Elaine Smith 18 Apr 2019
- Rhoda Grant 22 Apr 2019
- Claudia Beamish 23 Apr 2019
- Colin Smyth 1 May 2019
Source: the Scottish Parliament motions and amendments record.